Shares of Arcturus Therapeutics gained after the company said it would work with Thermo Fisher Scientific to advance a therapy for cystic fibrosis. The stock rose 5.8% to $7.29 in premarket trading ...
At BIO 2026, Thermo Fisher's Anil Kane explains how AI is reshaping CDMO workflows and what biotechs should prioritize when choosing a development partner. For Anil Kane, PhD, the question facing ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of Thermo Scientific™ Orbitrap™ mass spectrometry platforms, AI-enabled ...
Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of Thermo Scientific™ Orbitrap™ mass spectrometry platforms, AI-enabled software and integrated workflows ...
“If solution providers achieve their objectives, available AI tools may markedly shift the corporate decision-making calculus in favor of insourcing more IP work.” “Law firms face cliff edge as ...
As corporate America looks to redesign the workplace for the AI age, there’s a new kind of team gaining traction: the “pod.” Smaller than a traditional engineering group, pods are designed to move ...
GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. After years of wandering the depths of Planet 4546B alone, players ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its flagship U.S. Bioprocess Design Center (BDC) at the company’s ...
Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after initial rumors of a sale surfaced. The deal is worth $1.075 billion, consisting of cash ...
A pirate is only as good as their crew, and if you're wanting to set sail with your mates, there are a few ways to do it: host or join a friend's game locally, or host or join a dedicated independent ...
Central Works Co-directors, Jan Zvaifler and Gary Graves, will step down at the end of the 2026 season after a run of producing original plays for thirty-six years. As it currently stands, the Board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results